0.00Open29.00Pre Close0 Volume0 Open Interest1760.00Strike Price0.00Turnover6586.15%IV1119.00%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry29.00Extrinsic Value100Contract SizeAmericanOptions Type0.3374Delta0.0013Gamma5.06Leverage Ratio-172.1445Theta0.0002Rho1.71Eff Leverage0.0150Vega
NVIDIA Stock Discussion
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
the strategy today is
long TSLA and short NVDA
I mean break …. down
looking at green cloud up a head potential to shoot through
No comment yet